54763-99-4 Usage
Uses
Used in Pharmaceutical Industry:
3-heptyl-delta(1)-tetrahydrocannabinol is used as a research compound for investigating its potential therapeutic effects. It is being studied for its ability to produce similar effects to THC, which may have potential applications in treating various medical conditions such as pain, anxiety, and spasticity associated with multiple sclerosis.
Used in Drug Development:
3-heptyl-delta(1)-tetrahydrocannabinol is used as a lead compound in the development of new drugs targeting the cannabinoid receptors. Its potent and selective agonist activity at the CB1 receptor makes it a promising candidate for the development of medications with potential therapeutic benefits.
Used in Toxicological Research:
3-heptyl-delta(1)-tetrahydrocannabinol is used as a tool in toxicological research to study the potential health risks and side effects associated with synthetic cannabinoids. Understanding the pharmacological properties and safety profile of 3HH can help in the development of safer and more effective cannabinoid-based therapies.
Note: The uses mentioned above are based on the potential applications of 3-heptyl-delta(1)-tetrahydrocannabinol as a research compound and lead compound in drug development. However, it is important to emphasize that further research is needed to evaluate its safety and potential medical applications before it can be used in any therapeutic or commercial context.
Check Digit Verification of cas no
The CAS Registry Mumber 54763-99-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,7,6 and 3 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 54763-99:
(7*5)+(6*4)+(5*7)+(4*6)+(3*3)+(2*9)+(1*9)=154
154 % 10 = 4
So 54763-99-4 is a valid CAS Registry Number.
InChI:InChI=1/C23H34O2/c1-5-6-7-8-9-10-17-14-20(24)22-18-13-16(2)11-12-19(18)23(3,4)25-21(22)15-17/h13-15,18-19,24H,5-12H2,1-4H3/t18-,19-/m1/s1
54763-99-4Relevant academic research and scientific papers
CATALYTIC CANNABINOID PROCESSES AND PRECURSORS
-
, (2020/12/07)
The present disclosure relates to new cannabinoid sulfonate esters and processes for their use to prepare cannabinoids. The disclosure also relates to the use of catalysts and catalytic processes for the preparation of cannabinoids from the cannabinoid sulfonate esters.
